165 related articles for article (PubMed ID: 8435797)
1. Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy.
Bacci G; Picci P; Ferrari S; Orlandi M; Ruggieri P; Casadei R; Ferraro A; Biagini R; Battistini A
Cancer; 1993 Feb; 71(4):1224-30. PubMed ID: 8435797
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute.
Bacci G; Longhi A; Ferrari S; Lari S; Manfrini M; Donati D; Forni C; Versari M
Oncol Rep; 2002; 9(1):171-5. PubMed ID: 11748477
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum alkaline phosphatase in osteosarcoma.
Bacci G; Picci P; Orlandi M; Avella M; Manfrini M; Pignatti G; Dallari D; Manduchi R
Tumori; 1987 Aug; 73(4):331-6. PubMed ID: 3477902
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities.
Bacci G; Ferrari S; Sangiorgi L; Picci P; Casadei R; Orlandi M; Iantorno D; Battistini A; Zanone A
J Chemother; 1994 Jun; 6(3):204-10. PubMed ID: 7983504
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of serum alkaline phosphatase in osteosarcoma of the limbs.
Bacci G; Dallari D; Battistini A; Orlandi M; Ferrari S; Avella M; Picci P; Casadei R; Ruggieri P
Chir Organi Mov; 1992; 77(2):171-80. PubMed ID: 1499384
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma.
Garzotto CK; Berg J; Hoffmann WE; Rand WM
J Vet Intern Med; 2000; 14(6):587-92. PubMed ID: 11110379
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
Tomer G; Cohen IJ; Kidron D; Katz K; Yosipovitch Z; Meller I; Zaizov R
Int J Oncol; 1999 Jul; 15(1):179-85. PubMed ID: 10375613
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
[TBL] [Abstract][Full Text] [Related]
9. Changing pattern of relapse in osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy.
Bacci G; Ruggieri P; Picci P; Briccoli A; Ferraro A; Ferrari S; Tienghi A; Iantorno D; Campanacci M
J Chemother; 1995 Jun; 7(3):230-9. PubMed ID: 7562020
[TBL] [Abstract][Full Text] [Related]
10. COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.
Rodriguez NI; Hoots WK; Koshkina NV; Morales-Arias JA; Arndt CA; Inwards CY; Hawkins DS; Munsell MF; Kleinerman ES
J Pediatr Hematol Oncol; 2008 Jul; 30(7):507-12. PubMed ID: 18797196
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
Bacci G; Forni C; Longhi A; Ferrari S; Mercuri M; Bertoni F; Serra M; Briccoli A; Balladelli A; Picci P
J Surg Oncol; 2007 Aug; 96(2):118-23. PubMed ID: 17577221
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years.
Bacci G; Longhi A; Ferrari S; Briccoli A; Donati D; De Paolis M; Versari M
Tumori; 2004; 90(5):478-84. PubMed ID: 15656333
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute.
Ferrari S; Bertoni F; Mercuri M; Picci P; Giacomini S; Longhi A; Bacci G
Ann Oncol; 2001 Aug; 12(8):1145-50. PubMed ID: 11583198
[TBL] [Abstract][Full Text] [Related]
16. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
[TBL] [Abstract][Full Text] [Related]
17. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
[TBL] [Abstract][Full Text] [Related]
19. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
[TBL] [Abstract][Full Text] [Related]
20. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.
Briccoli A; Rocca M; Salone M; Guzzardella GA; Balladelli A; Bacci G
Surg Oncol; 2010 Dec; 19(4):193-9. PubMed ID: 19515554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
